Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Schneeweiss, A; Goerner, R; Hensel, M; Lauschner, I; Sinn, P; Kaul, S; Egerer, G; Beldermann, F; Geberth, M; Solomayer, E; Grischke, EM; Haas, R; Ho, AD; Bastert, G
   Tandem high-dose chemotherapy in high-risk primary breast cancer: A multivariate analysis and a matched-pair comparison with standard-dose chemotherapy
   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
   
   A. Schneeweiss et al., "Tandem high-dose chemotherapy in high-risk primary breast cancer: A multivariate analysis and a matched-pair comparison with standard-dose chemotherapy", BIOL BLOOD, 7(6), 2001, pp. 332-342
2. Feuerer, M; Beckhove, P; Bai, LH; Solomayer, EF; Bastert, G; Diel, IJ; Pedain, C; Oberniedermayr, M; Schirrmacher, V; Umansky, V
   Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow
   NATURE MEDICINE
   
   M. Feuerer et al., "Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow", NAT MED, 7(4), 2001, pp. 452-458
3. Schneeweiss, A; Hensel, M; Goerner, R; Khbeis, T; Hohaus, S; Egerer, G; Solomayer, E; Haas, R; Grischke, EM; Bastert, G; Ho, AD
   Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer
   STEM CELLS
   
   A. Schneeweiss et al., "Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer", STEM CELLS, 19(2), 2001, pp. 151-160
4. Schmoor, C; Sauerbrei, W; Bastert, G; Bojar, H; Schumacher, M
   Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF
   EUROPEAN JOURNAL OF CANCER
   
   C. Schmoor et al., "Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF", EUR J CANC, 37(9), 2001, pp. 1123-1131
5. Zhong, XY; Kaul, S; Bastert, G
   Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer
   ARCHIVES OF GYNECOLOGY AND OBSTETRICS
   
   X.Y. Zhong et al., "Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer", ARCH GYN OB, 264(4), 2001, pp. 177-181
6. Rimbach, S; Bastert, G; Wallwiener, D
   Technical results of falloposcopy for infertility diagnosis in a large multicentre study
   HUMAN REPRODUCTION
   
   S. Rimbach et al., "Technical results of falloposcopy for infertility diagnosis in a large multicentre study", HUM REPR, 16(5), 2001, pp. 925-930
7. Melsheimer, P; Klaes, R; Doeberitz, MV; Bastert, G
   Prospective clinical study comparing DNA flow cytometry and HPV typing as predictive tests for persistence and progression of CINI/II
   CYTOMETRY
   
   P. Melsheimer et al., "Prospective clinical study comparing DNA flow cytometry and HPV typing as predictive tests for persistence and progression of CINI/II", CYTOMETRY, 46(3), 2001, pp. 166-171
8. Feuerer, M; Rocha, M; Bai, LH; Umansky, V; Solomayer, EF; Bastert, G; Diel, IJ; Schirrmacher, V
   Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients
   INTERNATIONAL JOURNAL OF CANCER
   
   M. Feuerer et al., "Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients", INT J CANC, 92(1), 2001, pp. 96-105
9. Krapfl-Gast, AS; Schiesser, M; Straub, S; Bastert, G
   Listerial meningitis in a patient with metastatic breast cancer: A case report
   GEBURTSHILFE UND FRAUENHEILKUNDE
   
   A.S. Krapfl-Gast et al., "Listerial meningitis in a patient with metastatic breast cancer: A case report", GEBURTSH FR, 61(7), 2001, pp. 520-522
10. Schuhmacher, J; Kaul, S; Klivenyi, G; Junkermann, H; Magener, A; Henze, M; Doll, J; Haberkorn, U; Amelung, F; Bastert, G
    Immunoscintigraphy with positron emission tomography: Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies
    CANCER RESEARCH
    
    J. Schuhmacher et al., "Immunoscintigraphy with positron emission tomography: Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies", CANCER RES, 61(9), 2001, pp. 3712-3717
11. Chang-Claude, J; Eby, N; Kiechle, M; Bastert, G; Becher, H
    Breastfeeding and breast cancer risk by age 50 among women in Germany
    CANCER CAUSES & CONTROL
    
    J. Chang-Claude et al., "Breastfeeding and breast cancer risk by age 50 among women in Germany", CANC CAUSE, 11(8), 2000, pp. 687-695
12. Maksan, SM; Lehnert, T; Bastert, G; Herfarth, C
    Curative liver resection for metastatic breast cancer
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    
    S.M. Maksan et al., "Curative liver resection for metastatic breast cancer", EUR J SUR O, 26(3), 2000, pp. 209-212
13. Schmoor, C; Sauerbrei, W; Bastert, G; Schumacher, M
    Role of isolated locoregional recurrence of breast cancer: Results of fourprospective studies
    JOURNAL OF CLINICAL ONCOLOGY
    
    C. Schmoor et al., "Role of isolated locoregional recurrence of breast cancer: Results of fourprospective studies", J CL ONCOL, 18(8), 2000, pp. 1696-1708
14. Sauerbrei, W; Bastert, G; Bojar, H; Beyerle, C; Neumann, RLA; Schmoor, C; Schumacher, M
    Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: An update based on 10 years' follow-up
    JOURNAL OF CLINICAL ONCOLOGY
    
    W. Sauerbrei et al., "Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: An update based on 10 years' follow-up", J CL ONCOL, 18(1), 2000, pp. 94-101
15. Zhong, XY; Kaul, S; Lin, YS; Eichler, A; Bastert, G
    Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    X.Y. Zhong et al., "Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19", J CANC RES, 126(4), 2000, pp. 212-218
16. Solomayer, EF; Diel, IJ; Meyberg, GC; Gollan, C; Bastert, G
    Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
    BREAST CANCER RESEARCH AND TREATMENT
    
    E.F. Solomayer et al., "Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis", BREAST CANC, 59(3), 2000, pp. 271-278
17. Diel, IJ; Solomayer, EF; Bastert, G
    Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
    RADIOLOGE
    
    I.J. Diel et al., "Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer", RADIOLOGE, 40(8), 2000, pp. 681-687
18. Schmoor, C; Bastert, G; Dunst, J; Bojar, H; Christmann, D; Unbehaun, V; Tummers, G; Bauer, W; Sauerbrei, W; Schumacher, M
    Randomized trial on the effect of radiotherapy in addition to 6 cycles CMFin node-positive breast-cancer patients
    INTERNATIONAL JOURNAL OF CANCER
    
    C. Schmoor et al., "Randomized trial on the effect of radiotherapy in addition to 6 cycles CMFin node-positive breast-cancer patients", INT J CANC, 86(3), 2000, pp. 408-415
19. Fersis, N; Relakis, K; Bastert, G; Wallwiener, D
    Breast reconstruction with the "Fleur de lis"-technique of the latissimus dorsi myocutaneous flap: Cosmetic results and complications
    GEBURTSHILFE UND FRAUENHEILKUNDE
    
    N. Fersis et al., "Breast reconstruction with the "Fleur de lis"-technique of the latissimus dorsi myocutaneous flap: Cosmetic results and complications", GEBURTSH FR, 60(12), 2000, pp. 625-629
20. Diel, IJ; Solomayer, EF; Seibel, MJ; Pfeilschifter, J; Maisenbacher, H; Gollan, C; Pecherstorfer, M; Conradi, R; Kehr, G; Boehm, E; Armbruster, FP; Bastert, G
    Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis
    CLINICAL CANCER RESEARCH
    
    I.J. Diel et al., "Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis", CLIN CANC R, 5(12), 1999, pp. 3914-3919
21. Meyberg, GC; Solomayer, EF; Grischke, EM; Bastert, G
    Does the measurement of four fetal arteries provide more information than the measurement of just two arteries in prenatal Doppler sonography?
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY
    
    G.C. Meyberg et al., "Does the measurement of four fetal arteries provide more information than the measurement of just two arteries in prenatal Doppler sonography?", ULTRASOUN O, 13(6), 1999, pp. 407-414
22. Grischke, EM; Wallwiener, D; Bastert, G
    Uterine inversion combined with covered uterine rupture
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE
    
    E.M. Grischke et al., "Uterine inversion combined with covered uterine rupture", Z GEBU NEON, 203(3), 1999, pp. 123-125
23. Zhong, XY; Kaul, S; Eichler, A; Bastert, G
    Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    
    X.Y. Zhong et al., "Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow", ARCH GYN OB, 263(1-2), 1999, pp. 2-6
24. Guckel, B; Meyer, GC; Rudy, W; Batrla, R; Meuer, SC; Bastert, G; Wallwiener, D; Moebius, U
    Interleukin-12 requires initial CD80-mediated T-cell activation to supportimmune responses toward human breast and ovarian carcinoma
    CANCER GENE THERAPY
    
    B. Guckel et al., "Interleukin-12 requires initial CD80-mediated T-cell activation to supportimmune responses toward human breast and ovarian carcinoma", CANC GENE T, 6(3), 1999, pp. 228-237
25. Zhong, XY; Kaul, S; Diel, I; Eichler, A; Bastert, G
    Evaluation of sensitivity and specificity of GA733-2, MUC1-, CEA- and CK19-RT-PCT techniques for detection of tumour cells in bone marrow and leukapheresis products of patients with breast cancer.
    TUMORDIAGNOSTIK & THERAPIE
    
    X.Y. Zhong et al., "Evaluation of sensitivity and specificity of GA733-2, MUC1-, CEA- and CK19-RT-PCT techniques for detection of tumour cells in bone marrow and leukapheresis products of patients with breast cancer.", TUMORDIAGN, 20(5), 1999, pp. 144-152
26. Zhong, XY; Kaul, S; Diel, I; Eichler, A; Bastert, G
    Sensitivity and specificity of immunocytochemistry for the detection of tumour cells in the bone marrow of patients with breast cancer.
    TUMORDIAGNOSTIK & THERAPIE
    
    X.Y. Zhong et al., "Sensitivity and specificity of immunocytochemistry for the detection of tumour cells in the bone marrow of patients with breast cancer.", TUMORDIAGN, 20(2), 1999, pp. 39-44
27. Hohaus, S; Martin, S; Schneeweiss, A; Voso, MT; Schlenk, RF; Wallwiener, D; Bastert, G; Haas, R
    Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    S. Hohaus et al., "Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer", CANC CHEMOT, 44, 1999, pp. S13-S17
28. Aydeniz, B; Meyer, A; Geiss, HK; Grischke, EM; Genditzki, H; Merkle, EM; Bastert, G; Wallwiener, D
    Reduction of aseptic measures in gynecologic endoscopy: a comparative clinical trial
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    B. Aydeniz et al., "Reduction of aseptic measures in gynecologic endoscopy: a comparative clinical trial", EUR J OB GY, 87(2), 1999, pp. 169-173
29. Zhong, XY; Kaul, S; Diel, I; Eichler, A; Bastert, G
    Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    X.Y. Zhong et al., "Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products", J CANC RES, 125(5), 1999, pp. 286-291
30. Zhong, XY; Kaul, S; Thompson, J; Eichler, A; Bastert, G
    Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    X.Y. Zhong et al., "Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood", J CANC RES, 125(12), 1999, pp. 669-674
31. Hohaus, S; Funk, L; Martin, S; Schlenk, RF; Abdallah, A; Hahn, U; Egerer, G; Goldschmidt, H; Schneeweiss, A; Fersis, N; Kaul, S; Wallwiener, D; Bastert, G; Haas, R
    Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
    BRITISH JOURNAL OF CANCER
    
    S. Hohaus et al., "Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer", BR J CANC, 79(9-10), 1999, pp. 1500-1507
32. RIMBACH S; WALLWIENER D; BASTERT G
    LACTIFEROUS DUCT MICROENDOSCOPY
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
    
    S. Rimbach et al., "LACTIFEROUS DUCT MICROENDOSCOPY", MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 7(3), 1998, pp. 219-221
33. SINN HP; ANTON HW; MAGENER A; VONFOURNIER D; BASTERT G; OTTO HF
    EXTENSIVE AND PREDOMINANT IN-SITU COMPONENT IN BREAST-CARCINOMA - THEIR INFLUENCE ON TREATMENT RESULTS AFTER BREAST-CONSERVING THERAPY
    European journal of cancer
    
    H.P. Sinn et al., "EXTENSIVE AND PREDOMINANT IN-SITU COMPONENT IN BREAST-CARCINOMA - THEIR INFLUENCE ON TREATMENT RESULTS AFTER BREAST-CONSERVING THERAPY", European journal of cancer, 34(5), 1998, pp. 646-653
34. SCHMOOR C; SAUERBREI W; BASTERT G; RAUSCHECKER H; SCHUMACHER M
    DETERMINANTS OF PROGNOSIS AFTER FIRST ISOLATED LOCOREGIONAL RECURRENCE OF BREAST-CANCER
    European journal of cancer
    
    C. Schmoor et al., "DETERMINANTS OF PROGNOSIS AFTER FIRST ISOLATED LOCOREGIONAL RECURRENCE OF BREAST-CANCER", European journal of cancer, 34, 1998, pp. 34-34
35. SAUERBREI W; BASTERT G; BOJAR H; SCHMOOR C; SCHUMACHER M
    COMPARISON OF 3 VERSUS 6 CYCLES CMF IN NODE-POSITIVE BREAST-CANCER PATIENTS BASED ON 10 YEARS FOLLOW-UP
    European journal of cancer
    
    W. Sauerbrei et al., "COMPARISON OF 3 VERSUS 6 CYCLES CMF IN NODE-POSITIVE BREAST-CANCER PATIENTS BASED ON 10 YEARS FOLLOW-UP", European journal of cancer, 34, 1998, pp. 165-165
36. SCHMOOR C; BASTERT G; BOJAR H; SAUERBREI W; SCHUMACHER M
    EFFECT OF RADIOTHERAPY IN ADDITION TO 6 CYCLES CMF IN NODE-POSITIVE BREAST-CANCER PATIENTS
    European journal of cancer
    
    C. Schmoor et al., "EFFECT OF RADIOTHERAPY IN ADDITION TO 6 CYCLES CMF IN NODE-POSITIVE BREAST-CANCER PATIENTS", European journal of cancer, 34, 1998, pp. 263-263
37. PRIFTI S; FERSIS N; SILLEM M; SZEKELYI M; RUNNEBAUM B; BASTERT G
    INVOLVEMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR PAI-1 IN IN-VITRO GROWTH OF HUMAN BREAST-CANCER CELL-LINES
    European journal of cancer
    
    S. Prifti et al., "INVOLVEMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR PAI-1 IN IN-VITRO GROWTH OF HUMAN BREAST-CANCER CELL-LINES", European journal of cancer, 34, 1998, pp. 13-13
38. FERSIS N; KRAINICK U; FRISE H; THRON S; SZEKELYI M; WITTMANN G; WALLWIENER D; BASTERT G
    PROGNOSTIC VALUE OF PLASMINOGENAKTIVATOR INHIBITOR TYPE-1 AND TYPE-2 IN PRIMARY BREAST-CANCER
    European journal of cancer
    
    N. Fersis et al., "PROGNOSTIC VALUE OF PLASMINOGENAKTIVATOR INHIBITOR TYPE-1 AND TYPE-2 IN PRIMARY BREAST-CANCER", European journal of cancer, 34, 1998, pp. 39-39
39. SOLOMAYER EF; DIEL IJ; GOLLAN C; MEYBERG G; BODE S; WALLWIENER D; BASTERT G
    UROKINASE PLASMINOGEN-ACTIVATOR AND CATHEPSIN-D IN MICROMETASTATIC CELLS OF PATIENTS WITH PRIMARY BREAST-CANCER
    European journal of cancer
    
    E.F. Solomayer et al., "UROKINASE PLASMINOGEN-ACTIVATOR AND CATHEPSIN-D IN MICROMETASTATIC CELLS OF PATIENTS WITH PRIMARY BREAST-CANCER", European journal of cancer, 34, 1998, pp. 41-41
40. DIEL IJ; SOLOMAYER EF; GOLLAN C; WALLWIENER D; BASTERT G
    REDUCTION OF METASTASES IN BREAST-CANCER PATIENTS BY ADJUVANT BISPHOSPHONATE TREATMENT
    European journal of cancer
    
    I.J. Diel et al., "REDUCTION OF METASTASES IN BREAST-CANCER PATIENTS BY ADJUVANT BISPHOSPHONATE TREATMENT", European journal of cancer, 34, 1998, pp. 89-89
41. RENSING K; STOCKHAUSEN LV; WALLWIENER D; GRISCHKE EM; BASTERT G
    ASSESSMENT OF CHANGES IN LIFE QUALITY OF BREAST-CANCER PATIENTS UNDERADJUVANT CMF-CHEMOTHERAPY BY MEANS OF THE EORTC QLQ-C30
    European journal of cancer
    
    K. Rensing et al., "ASSESSMENT OF CHANGES IN LIFE QUALITY OF BREAST-CANCER PATIENTS UNDERADJUVANT CMF-CHEMOTHERAPY BY MEANS OF THE EORTC QLQ-C30", European journal of cancer, 34, 1998, pp. 108-108
42. WALLWIENER D; AYDENIZ B; GRISCHKE EM; ABBASI I; BASTERT G
    INTRACERVICAL PROSTAGLANDIN E-2 FOR INDUCTION OF LABOR - A COMPARATIVE-ANALYSIS IN 171 PATIENTS WITH 2 DIFFERENT PG E-2 PREPARATIONS WITH REGARD TO COURSE OF LABOR AND FETAL-OUTCOME
    Zeitschrift fur Geburtshilfe und Perinatologie
    
    D. Wallwiener et al., "INTRACERVICAL PROSTAGLANDIN E-2 FOR INDUCTION OF LABOR - A COMPARATIVE-ANALYSIS IN 171 PATIENTS WITH 2 DIFFERENT PG E-2 PREPARATIONS WITH REGARD TO COURSE OF LABOR AND FETAL-OUTCOME", Zeitschrift fur Geburtshilfe und Perinatologie, 202(4), 1998, pp. 149-153
43. AYDENIZ B; WALLWIENER D; KOCER C; GRISCHKE EM; DIEL IJ; SOHN C; BASTERT G
    MYOMA INDUCED COMPLICATIONS IN PREGNANCY - A COMPARATIVE-ANALYSIS OF THE COURSE OF PREGNANCIES WITH AND WITHOUT MYOMAS
    Zeitschrift fur Geburtshilfe und Perinatologie
    
    B. Aydeniz et al., "MYOMA INDUCED COMPLICATIONS IN PREGNANCY - A COMPARATIVE-ANALYSIS OF THE COURSE OF PREGNANCIES WITH AND WITHOUT MYOMAS", Zeitschrift fur Geburtshilfe und Perinatologie, 202(4), 1998, pp. 154-158
44. WACKER J; WERNER P; WALTERSACK I; BASTERT G
    TREATMENT OF HYPERTENSION IN PATIENTS WITH PREECLAMPSIA - A PROSPECTIVE PARALLEL-GROUP STUDY COMPARING DIHYDRALAZINE WITH URAPIDIL
    Nephrology, dialysis, transplantation
    
    J. Wacker et al., "TREATMENT OF HYPERTENSION IN PATIENTS WITH PREECLAMPSIA - A PROSPECTIVE PARALLEL-GROUP STUDY COMPARING DIHYDRALAZINE WITH URAPIDIL", Nephrology, dialysis, transplantation, 13(2), 1998, pp. 318-325
45. SOLOMAYER EF; DIEL IJ; KREMPIEN B; MEYBERG GC; GOLLAN C; KRAINICK U; WALLWIENER D; BASTERT G
    RESULTS OF ILIAC CREST BIOPSIES TAKEN FROM 1465 PATIENTS WITH PRIMARYBREAST-CANCER
    Journal of cancer research and clinical oncology
    
    E.F. Solomayer et al., "RESULTS OF ILIAC CREST BIOPSIES TAKEN FROM 1465 PATIENTS WITH PRIMARYBREAST-CANCER", Journal of cancer research and clinical oncology, 124(1), 1998, pp. 44-48
46. Huober, J; Schneeweiss, A; Hohaus, S; Wittmann, G; Meyer, A; Martin, S; Goldschmidt, H; Bastert, G; Haas, R; Wallwiener, D
    Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    J. Huober et al., "Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer", J CANC RES, 124(12), 1998, pp. 690-694
47. SOLOMAYER EF; DIEL IJ; MEYBERG GC; GOLLAN C; BODE S; WALLWIENER D; BASTERT G
    PROGNOSTIC RELEVANCE OF CATHEPSIN-D DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER
    Breast cancer research and treatment
    
    E.F. Solomayer et al., "PROGNOSTIC RELEVANCE OF CATHEPSIN-D DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER", Breast cancer research and treatment, 49(2), 1998, pp. 145-154
48. ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; BENRAADT J; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; GATES GD; POWELL J; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; BERRY D; BROADWATER G; CIRRINCIONE C; MUSS H; NORTON L; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; GORDON NH; DAVIS HL; ROMESTAING P; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; PORTNOJ SM; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; COMIS RL; DAVIDSON NE; GRAY R; ROBERT N; TORMEY DC; WOOD W; CHETTY U; FORREST P; JACK W; ROSSBACH J; SYLVESTER RJ; VANDEVELDE CJH; CUNNINGHAM MP; BONNETERRE J; FUMOLEAU P; NAMER M; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DESCHRYVER A; BELFIGLIO M; MARI E; NICOLUCCI A; SCORPIGLIONE N; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; RUBAGOTTI A; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLAFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVILLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; WELVAART K; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; INGLE JN; SUMAN VJ; BUZDAR AU; SMITH T; HAKES T; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; MYLES JD; PATER JL; PRITCHARD KI; ANDERSON S; BROWN A; BRYANT J; COSTANTINO J; DIGNAM J; FISHER B; REDMOND C; WIEAND S; WOLMARK N; JACKSON IM; PALMER MK; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; UEO H; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; HARRIS A; BEIGHTON A; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JACKSON D; JAMES S; LAU E; MEAD G; NAUGHTEN A; PETO R; TOOTH A; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CI; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; GEORGE WD; GOULD A; STEWART HJ; STRONER P; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; GNANT M; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
    POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
    Lancet
    
    O. Abe et al., "POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS", Lancet, 352(9132), 1998, pp. 930-942
49. HOHAUS S; WALLWIENER D; MARTIN S; VOSO MT; HUOBER J; FERSIS N; BASTERT G; HAAS R
    EFFICACY AND TOXICITY OF SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK BREAST-CANCER
    Seminars in oncology
    
    S. Hohaus et al., "EFFICACY AND TOXICITY OF SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK BREAST-CANCER", Seminars in oncology, 25(2), 1998, pp. 7-11
50. WACKER J; KYELEM D; BASTERT G; UTZ B; LANKOANDE J
    INTRODUCTION OF A SIMPLIFIED ROUND PARTOGRAM IN RURAL MATERNITY UNITS- SENO PROVINCE, BURKINA-FASO, WEST-AFRICA
    Tropical doctor
    
    J. Wacker et al., "INTRODUCTION OF A SIMPLIFIED ROUND PARTOGRAM IN RURAL MATERNITY UNITS- SENO PROVINCE, BURKINA-FASO, WEST-AFRICA", Tropical doctor, 28(3), 1998, pp. 146-152
51. WACKER J; UTE B; KYELEM D; BASTERT G
    THE LATENT PHASE - NO OBSTACLE FOR THE USE OF PARTOGRAMS
    Tropical doctor
    
    J. Wacker et al., "THE LATENT PHASE - NO OBSTACLE FOR THE USE OF PARTOGRAMS", Tropical doctor, 28(2), 1998, pp. 120-121
52. DIEL IJ; SOLOMAYER EF; COSTA SD; GOLLAN C; GOERNER R; WALLWIENER D; KAUFMANN M; BASTERT G
    REDUCTION IN NEW METASTASES IN BREAST-CANCER WITH ADJUVANT CLODRONATETREATMENT
    The New England journal of medicine
    
    I.J. Diel et al., "REDUCTION IN NEW METASTASES IN BREAST-CANCER WITH ADJUVANT CLODRONATETREATMENT", The New England journal of medicine, 339(6), 1998, pp. 357-363
53. HOOS A; HEPP HH; KAUL S; AHLERT T; BASTERT G; WALLWIENER D
    TELOMERASE ACTIVITY CORRELATES WITH TUMOR AGGRESSIVENESS AND REFLECTSTHERAPY EFFECT IN BREAST-CANCER
    International journal of cancer
    
    A. Hoos et al., "TELOMERASE ACTIVITY CORRELATES WITH TUMOR AGGRESSIVENESS AND REFLECTSTHERAPY EFFECT IN BREAST-CANCER", International journal of cancer, 79(1), 1998, pp. 8-12
54. WALLWIENER D; EBLE MJ; SOLOMAYER EF; JUNKERMANN H; KAUFMANN M; DIEL IJ; GRISCHKE EM; SCHONIG T; WANNENMACHER M; BASTERT G
    RADICAL TUMOR DEBULKING AND INTRAOPERATIV E RADIATION-THERAPY (IORT) FOR PELVIC RECURRENCES OF GYNECOLOGICAL CARCINOMAS
    Geburtshilfe und Frauenheilkunde
    
    D. Wallwiener et al., "RADICAL TUMOR DEBULKING AND INTRAOPERATIV E RADIATION-THERAPY (IORT) FOR PELVIC RECURRENCES OF GYNECOLOGICAL CARCINOMAS", Geburtshilfe und Frauenheilkunde, 58(1), 1998, pp. 19-25
55. WALLWIENER D; DIEL IJ; SOLOMAYER EF; SCHOENMAKERS C; GRISCHKE EM; JUNKERMANN H; SINN HP; KAUFMANN M; BASTERT G
    NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVAN CED CARCINOMAS OF THE BREAST - TUMOR-REGRESSION AND PERIOPERATIVE COMPLICATIONS
    Geburtshilfe und Frauenheilkunde
    
    D. Wallwiener et al., "NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVAN CED CARCINOMAS OF THE BREAST - TUMOR-REGRESSION AND PERIOPERATIVE COMPLICATIONS", Geburtshilfe und Frauenheilkunde, 58(1), 1998, pp. 44-50
56. RIMBACH S; WALLWIENER D; BARTH C; BEKEREDJIAN R; HARDT S; BASTERT G
    INTRALUMINAL ULTRASOUND IMAGING OF THE FALLOPIAN-TUBE WALL - RESULTS OF STANDARDIZED IN-VITRO INVESTIGATIONS OF PIG AND HUMAN TUBAL SPECIMENS
    Fertility and sterility
    
    S. Rimbach et al., "INTRALUMINAL ULTRASOUND IMAGING OF THE FALLOPIAN-TUBE WALL - RESULTS OF STANDARDIZED IN-VITRO INVESTIGATIONS OF PIG AND HUMAN TUBAL SPECIMENS", Fertility and sterility, 70(1), 1998, pp. 161-164
57. WALLWIENER D; MEYER A; BASTERT G
    ADHESION FORMATION OF THE PARIETAL AND VISCERAL PERITONEUM - AN EXPLANATION FOR THE CONTROVERSY ON THE USE OF AUTOLOGOUS AND ALLOPLASTIC BARRIERS
    Fertility and sterility
    
    D. Wallwiener et al., "ADHESION FORMATION OF THE PARIETAL AND VISCERAL PERITONEUM - AN EXPLANATION FOR THE CONTROVERSY ON THE USE OF AUTOLOGOUS AND ALLOPLASTIC BARRIERS", Fertility and sterility, 69(1), 1998, pp. 132-137
58. WACKER J; SCHULZ M; FRUHAUF J; CHIWORA FM; SOLOMAYER E; BASTERT G
    SEASONAL CHANGE IN THE INCIDENCE OF PREECLAMPSIA IN ZIMBABWE
    Acta obstetricia et gynecologica Scandinavica
    
    J. Wacker et al., "SEASONAL CHANGE IN THE INCIDENCE OF PREECLAMPSIA IN ZIMBABWE", Acta obstetricia et gynecologica Scandinavica, 77(7), 1998, pp. 712-716
59. HAMANN U; BRAUCH H; GARVIN AM; BASTERT G; SCOTT RJ
    GERMAN FAMILY STUDY ON HEREDITARY BREAST AND OR OVARIAN-CANCER - GERMLINE MUTATION ANALYSIS OF THE BRCAI GENE/
    Genes, chromosomes & cancer
    
    U. Hamann et al., "GERMAN FAMILY STUDY ON HEREDITARY BREAST AND OR OVARIAN-CANCER - GERMLINE MUTATION ANALYSIS OF THE BRCAI GENE/", Genes, chromosomes & cancer, 18(2), 1997, pp. 126-132
60. FERSIS N; HAAS R; WALLWIENER D; HOHAUS S; FRUHAUF S; BASTERT G
    HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER
    Breast
    
    N. Fersis et al., "HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER", Breast, 6(5), 1997, pp. 321-321
61. HAMANN U; COSTA SD; GOTTE K; HUOBER J; SOLOMAYER EF; KAUFMANN M; BASTERT G; KOMITOWSKI D
    ALLELIC IMBALANCE IN 3 DISTINCT REGIONS ON CHROMOSOME 17Q IN SPORADICBREAST-CANCER CORRELATES WITH PROGNOSTIC PARAMETERS
    Breast
    
    U. Hamann et al., "ALLELIC IMBALANCE IN 3 DISTINCT REGIONS ON CHROMOSOME 17Q IN SPORADICBREAST-CANCER CORRELATES WITH PROGNOSTIC PARAMETERS", Breast, 6(1), 1997, pp. 1-5
62. HAAS R; SCHMID H; HAHN U; HOHAUS S; GOLDSCHMIDT H; MUREA S; KAUFMANN M; WANNENMACHER M; WALLWIENER D; BASTERT G; HUNSTEIN W
    TANDEM HIGH-DOSE THERAPY WITH IFOSFAMIDE, EPIRUBICIN, CARBOPLATIN ANDPERIPHERAL-BLOOD STEM-CELL SUPPORT IS AN EFFECTIVE ADJUVANT TREATMENTFOR HIGH-RISK PRIMARY BREAST-CANCER
    European journal of cancer
    
    R. Haas et al., "TANDEM HIGH-DOSE THERAPY WITH IFOSFAMIDE, EPIRUBICIN, CARBOPLATIN ANDPERIPHERAL-BLOOD STEM-CELL SUPPORT IS AN EFFECTIVE ADJUVANT TREATMENTFOR HIGH-RISK PRIMARY BREAST-CANCER", European journal of cancer, 33(3), 1997, pp. 372-378
63. DIEL IJ; SOLOMAYER EF; GOLLAN C; WALLWIENER D; BASTERT G
    PROGNOSTIC IMPACT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH EARLY BREAST-CANCER (T1)
    European journal of cancer
    
    I.J. Diel et al., "PROGNOSTIC IMPACT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH EARLY BREAST-CANCER (T1)", European journal of cancer, 33, 1997, pp. 340-340
64. SOLOMAYER EF; DIEL IJ; GOLLAN C; WALLWIENER D; GISECKE F; KAUL S; BASTERT G
    TUMOR-CELL DETECTION IN BREAST-CANCER PATIENTS BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY
    European journal of cancer
    
    E.F. Solomayer et al., "TUMOR-CELL DETECTION IN BREAST-CANCER PATIENTS BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY", European journal of cancer, 33, 1997, pp. 342-342
65. GUCKEL B; MEYER CC; WALLWIENER D; RUDY W; MEUER S; BASTERT G; MOEBIUS U
    INTERLEUKIN-12 SUPPORTS IMMUNE-RESPONSES TOWARDS HUMAN BREAST AND OVARIAN CARCINOMAS FOLLOWING INITIAL CD80 MEDIATED T-CELL ACTIVATION
    European journal of cancer
    
    B. Guckel et al., "INTERLEUKIN-12 SUPPORTS IMMUNE-RESPONSES TOWARDS HUMAN BREAST AND OVARIAN CARCINOMAS FOLLOWING INITIAL CD80 MEDIATED T-CELL ACTIVATION", European journal of cancer, 33, 1997, pp. 366-366
66. HUOBER J; WALLWIENER D; FERSIS N; BASTERT G
    HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT (PBSC) IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)
    European journal of cancer
    
    J. Huober et al., "HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT (PBSC) IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)", European journal of cancer, 33, 1997, pp. 415-415
67. GRISCHKE EM; FELDERBAUM R; BREITBACH GP; BASTERT G
    ADJUVANT CISPLATIN AND TREOSULFAN CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER STAGE I-III AFTER COMPLETE SURGICAL RESECTION
    European journal of cancer
    
    E.M. Grischke et al., "ADJUVANT CISPLATIN AND TREOSULFAN CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER STAGE I-III AFTER COMPLETE SURGICAL RESECTION", European journal of cancer, 33, 1997, pp. 540-540
68. WALLWIENER D; BREITBACH GP; BASTERT G
    THE VALUE OF NEOADJUVANT CHEMOTHERAPY (NACT) AFTER SURGICAL-PATHOLOGICAL STAGING (SPS) VS. FAILED DEBULKING (FD) FOR INOPERABLE OVARIAN-CANCER (IOC) AND SUBSEQUENT INTERVENTIONAL LAPAROTOMY (ILAP)
    European journal of cancer
    
    D. Wallwiener et al., "THE VALUE OF NEOADJUVANT CHEMOTHERAPY (NACT) AFTER SURGICAL-PATHOLOGICAL STAGING (SPS) VS. FAILED DEBULKING (FD) FOR INOPERABLE OVARIAN-CANCER (IOC) AND SUBSEQUENT INTERVENTIONAL LAPAROTOMY (ILAP)", European journal of cancer, 33, 1997, pp. 550-550
69. JUNKERMANN H; KNOPP MV; SINN HP; LEPPIEN G; WALLWIENER D; VONFOURNIER D; BASTERT G
    RESPONSE TO PRIMARY CHEMOTHERAPY OF BREAST-CANCER
    European journal of cancer
    
    H. Junkermann et al., "RESPONSE TO PRIMARY CHEMOTHERAPY OF BREAST-CANCER", European journal of cancer, 33, 1997, pp. 652-652
70. FERSIS N; HAAS R; WALLWIENER D; HOHAUS S; HUOBER J; BASTERT G
    HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER
    European journal of cancer
    
    N. Fersis et al., "HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER", European journal of cancer, 33, 1997, pp. 661-661
71. DIEL IJ; SOLOMAYER EF; GOLLAN C; WALLWIENER D; BASTERT G
    CLINICAL COURSE, PROGNOSIS AND THERAPY OF BONE METASTASES IN BREAST-CANCER PATIENTS
    European journal of cancer
    
    I.J. Diel et al., "CLINICAL COURSE, PROGNOSIS AND THERAPY OF BONE METASTASES IN BREAST-CANCER PATIENTS", European journal of cancer, 33, 1997, pp. 665-665
72. MOHLER M; RENSING K; GUTZLER F; GRISCHKE EM; WALLWIENER D; BASTERT G; STREMMEL W
    TREATMENT AND PROGNOSIS OF MALE BREAST-CANCER - THE HEIDELBERG EXPERIENCE
    European journal of cancer
    
    M. Mohler et al., "TREATMENT AND PROGNOSIS OF MALE BREAST-CANCER - THE HEIDELBERG EXPERIENCE", European journal of cancer, 33, 1997, pp. 696-696
73. GOLLAN C; DIEL IJ; SOLOMAYER EF; KUHNER S; WALLWIENER D; BASTERT G
    IMMUNOREACTIVE DETECTION OF PARATHORMONE RELATED PROTEIN (PTHRP) IN PRIMARY BREAST CANCERS IS A GOOD PROGNOSTIC FACTOR FOR SUBSEQUENT BONE METASTASES
    European journal of cancer
    
    C. Gollan et al., "IMMUNOREACTIVE DETECTION OF PARATHORMONE RELATED PROTEIN (PTHRP) IN PRIMARY BREAST CANCERS IS A GOOD PROGNOSTIC FACTOR FOR SUBSEQUENT BONE METASTASES", European journal of cancer, 33, 1997, pp. 881-881
74. HOOS A; HEPP HH; KAUL S; AHLERT T; WALLWIENER D; BASTERT G
    PROGNOSTIC-SIGNIFICANCE OF TELOMERASE ACTIVITY IN BREAST-CANCER
    European journal of cancer
    
    A. Hoos et al., "PROGNOSTIC-SIGNIFICANCE OF TELOMERASE ACTIVITY IN BREAST-CANCER", European journal of cancer, 33, 1997, pp. 894-894
75. WALLWIENER D; KUREK R; ANGIOLI R; JANICEK M; PENALVER M; BLATTER J; EBLE E; DIEL IJ; BASTERT G; SEVIN BU
    RADIATION ENHANCEMENT OF GEMCITABINE(R) IN 3 HUMAN CERVICAL-CANCER CELL-LINES
    European journal of cancer
    
    D. Wallwiener et al., "RADIATION ENHANCEMENT OF GEMCITABINE(R) IN 3 HUMAN CERVICAL-CANCER CELL-LINES", European journal of cancer, 33, 1997, pp. 923-923
76. RIMBACH S; WALLWIENER D; BASTERT G
    METHODS OF TRANSCERVICAL FALLOSCOPY
    Archives of gynecology and obstetrics
    
    S. Rimbach et al., "METHODS OF TRANSCERVICAL FALLOSCOPY", Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 255-257
77. BASTERT G
    CERVICAL-CANCER
    Archives of gynecology and obstetrics
    
    G. Bastert, "CERVICAL-CANCER", Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 364-367
78. SOHN C; BELDERMANN F; BASTERT G
    SONOGRAPHIC BLOOD-FLOW MEASUREMENTS IN MALIGNANT BREAST-TUMORS - A POTENTIAL NEW PROGNOSTIC FACTOR
    Surgical endoscopy
    
    C. Sohn et al., "SONOGRAPHIC BLOOD-FLOW MEASUREMENTS IN MALIGNANT BREAST-TUMORS - A POTENTIAL NEW PROGNOSTIC FACTOR", Surgical endoscopy, 11(9), 1997, pp. 957-960
79. AHLERT T; SAUERBREI W; BASTERT G; RUHLAND S; BARTIK B; SIMIANTONAKI N; SCHUMACHER J; HACKER B; SCHUMACHER M; SCHIRRMACHER V
    TUMOR-CELL NUMBER AND VIABILITY AS QUALITY AND EFFICACY PARAMETERS OFAUTOLOGOUS VIRUS-MODIFIED CANCER VACCINES IN PATIENTS WITH BREAST OR OVARIAN-CANCER
    Journal of clinical oncology
    
    T. Ahlert et al., "TUMOR-CELL NUMBER AND VIABILITY AS QUALITY AND EFFICACY PARAMETERS OFAUTOLOGOUS VIRUS-MODIFIED CANCER VACCINES IN PATIENTS WITH BREAST OR OVARIAN-CANCER", Journal of clinical oncology, 15(4), 1997, pp. 1354-1366
80. MORANO I; KOEHLEN S; HAASE H; ERB G; BALTAS LG; RIMBACH S; WALLWIENER D; BASTERT G
    ALTERNATIVE SPLICING AND CYCLING KINETICS OF MYOSIN CHANGE DURING HYPERTROPHY OF HUMAN SMOOTH-MUSCLE CELLS
    Journal of cellular biochemistry
    
    I. Morano et al., "ALTERNATIVE SPLICING AND CYCLING KINETICS OF MYOSIN CHANGE DURING HYPERTROPHY OF HUMAN SMOOTH-MUSCLE CELLS", Journal of cellular biochemistry, 64(2), 1997, pp. 171-181
81. SINN HP; HAAG D; EHEMANN V; MAGENER A; GOERTTLER K; BASTERT G; OTTO HF
    DNA CYTOMETRY IN BREAST-CANCER - REVIEW O F METHODS AND ITS ROLE IN PROGNOSTIC EVALUATION
    Der Pathologe
    
    H.P. Sinn et al., "DNA CYTOMETRY IN BREAST-CANCER - REVIEW O F METHODS AND ITS ROLE IN PROGNOSTIC EVALUATION", Der Pathologe, 18(1), 1997, pp. 19-26
82. SINN HP; KELLERHOFF NM; KELLERHOFF R; BASTERT G; OTTO HF
    SUBTYPING AND PROGNOSTIC EVALUATION IN IN VASIVE LOBULAR CARCINOMA OFTHE BREAST
    Der Pathologe
    
    H.P. Sinn et al., "SUBTYPING AND PROGNOSTIC EVALUATION IN IN VASIVE LOBULAR CARCINOMA OFTHE BREAST", Der Pathologe, 18(1), 1997, pp. 37-44
83. CHANGCLAUDE J; BECHER H; EBY N; BASTERT G; WAHRENDORF J; HAMANN U
    MODIFYING EFFECT OF REPRODUCTIVE RISK-FACTORS ON THE AGE AT ONSET OF BREAST-CANCER FOR GERMAN BRCA1 MUTATION CARRIERS
    Journal of cancer research and clinical oncology
    
    J. Changclaude et al., "MODIFYING EFFECT OF REPRODUCTIVE RISK-FACTORS ON THE AGE AT ONSET OF BREAST-CANCER FOR GERMAN BRCA1 MUTATION CARRIERS", Journal of cancer research and clinical oncology, 123(5), 1997, pp. 272-279
84. SOHN C; BELDERMANN F; FREY H; REINHARDT S; SOHN J; BASTERT G
    BLOOD-FLOW DIAGNOSTICS OF BREAST-TUMORS UNDER INCREASED BLOOD-PRESSURE - NEW POSSIBILITIES IN ESTABLISHING THE NATURE OF THE TUMOR
    Radiologe
    
    C. Sohn et al., "BLOOD-FLOW DIAGNOSTICS OF BREAST-TUMORS UNDER INCREASED BLOOD-PRESSURE - NEW POSSIBILITIES IN ESTABLISHING THE NATURE OF THE TUMOR", Radiologe, 37(8), 1997, pp. 643-650
85. HAMANN U; HANER M; STOSIEK U; BASTERT G; SCOTT RJ
    LOW-FREQUENCY OF BRCA1 GERMLINE MUTATIONS IN 45 GERMAN BREAST OVARIANCANCER FAMILIES/
    Journal of Medical Genetics
    
    U. Hamann et al., "LOW-FREQUENCY OF BRCA1 GERMLINE MUTATIONS IN 45 GERMAN BREAST OVARIANCANCER FAMILIES/", Journal of Medical Genetics, 34(11), 1997, pp. 884-888
86. GAUWERKY JFH; REINHARD B; OPPELT P; BASTERT G; KAUFMANN M
    RECONSTRUCTION OF THE VAGINA USING NEW EN DOSCOPIC TECHNIQUES
    Der Gynakologe
    
    J.F.H. Gauwerky et al., "RECONSTRUCTION OF THE VAGINA USING NEW EN DOSCOPIC TECHNIQUES", Der Gynakologe, 30(6), 1997, pp. 507-514
87. WACKER J; BUTZKE S; WERNER P; SCHULZ M; UTZ B; BASTERT G
    OBSTETRICAL PROBLEMS IN THIRD-WORLD COUNT RIES
    Der Gynakologe
    
    J. Wacker et al., "OBSTETRICAL PROBLEMS IN THIRD-WORLD COUNT RIES", Der Gynakologe, 30(12), 1997, pp. 947-954
88. BASTERT G; WACKER J; WERNER P; BUTZKE S; SCHULZ M
    CRITERIA FOR GYNECOLOGICAL SERVICES
    Der Gynakologe
    
    G. Bastert et al., "CRITERIA FOR GYNECOLOGICAL SERVICES", Der Gynakologe, 30(12), 1997, pp. 955-957
89. SCHEUERMANN W; RENSING K; SCHMID H; WALLWIENER D; BASTERT G
    MORTALITY OF MALIGNANT BREAST AND GENITAL TUMORS IN WOMEN IN THE FEDERAL-REPUBLIC-OF-GERMANY FROM 1970 TO 1994
    Geburtshilfe und Frauenheilkunde
    
    W. Scheuermann et al., "MORTALITY OF MALIGNANT BREAST AND GENITAL TUMORS IN WOMEN IN THE FEDERAL-REPUBLIC-OF-GERMANY FROM 1970 TO 1994", Geburtshilfe und Frauenheilkunde, 57(8), 1997, pp. 423-428
90. MELSHEIMER P; WALLWIENER D; HAHN U; HEBERLING D; DOEBERITZ MVK; RUMMEL HH; BASTERT G
    ORGAN-PRESERVING LASER-SURGERY OF VULVAR INTRAEPITHELIAL NEOPLASIA (VIN) AND VAGINAL INTRAEPITHELIAL NEOPLASIA (VAIN)) - CHANCES AND LIMITATIONS
    Geburtshilfe und Frauenheilkunde
    
    P. Melsheimer et al., "ORGAN-PRESERVING LASER-SURGERY OF VULVAR INTRAEPITHELIAL NEOPLASIA (VIN) AND VAGINAL INTRAEPITHELIAL NEOPLASIA (VAIN)) - CHANCES AND LIMITATIONS", Geburtshilfe und Frauenheilkunde, 57(8), 1997, pp. 440-446
91. GRISCHKE EM; WALLWIENER D; KAUFMANN M; SINN HP; SOLOMAYER E; BASTERT G
    ANGIONEOGENESIS IN BREAST-CANCER
    Geburtshilfe und Frauenheilkunde
    
    E.M. Grischke et al., "ANGIONEOGENESIS IN BREAST-CANCER", Geburtshilfe und Frauenheilkunde, 57(6), 1997, pp. 321-327
92. DIEL IJ; KAUFMANN M; SOLOMAYER EF; WALLWIENER D; GOLLAN C; GOERNER R; KAUL S; COSTA SD; VONMINCKWITZ G; HOLLE R; BASTERT G
    PROGNOSTIC-SIGNIFICANCE OF TUMOR-CELL DET ECTION IN COMPARISON TO NODAL STATUS IN 1026 PATIENTS WITH PRIMARY BREAST-CANCER
    Geburtshilfe und Frauenheilkunde
    
    I.J. Diel et al., "PROGNOSTIC-SIGNIFICANCE OF TUMOR-CELL DET ECTION IN COMPARISON TO NODAL STATUS IN 1026 PATIENTS WITH PRIMARY BREAST-CANCER", Geburtshilfe und Frauenheilkunde, 57(6), 1997, pp. 333-341
93. MALEIKARABE A; WALLWIENER D; SOLOMAYER E; GRISCHKE EM; BASTERT G
    EFFECT OF ENDOGENOUS AND EXOGENOUS RISK-F ACTORS ON THE FEMALE PELVICFLOOR IN CORRELATION WITH THE PREVALENCE OF STRESS-INCONTINENCE OF URINE - OBJECTIVE
    Geburtshilfe und Frauenheilkunde
    
    A. Maleikarabe et al., "EFFECT OF ENDOGENOUS AND EXOGENOUS RISK-F ACTORS ON THE FEMALE PELVICFLOOR IN CORRELATION WITH THE PREVALENCE OF STRESS-INCONTINENCE OF URINE - OBJECTIVE", Geburtshilfe und Frauenheilkunde, 57(4), 1997, pp. 183-187
94. GRISCHKE EM; WALLWIENER D; SCHMID H; KAUFMANN M; BASTERT G
    INTRAPERITONEAL THERAPY OF OVARIAN-CARCIN OMA WITH CYTOSTATICS AND CYTOKINES APPLIED BY INSERTING PART SYSTEMS
    Geburtshilfe und Frauenheilkunde
    
    E.M. Grischke et al., "INTRAPERITONEAL THERAPY OF OVARIAN-CARCIN OMA WITH CYTOSTATICS AND CYTOKINES APPLIED BY INSERTING PART SYSTEMS", Geburtshilfe und Frauenheilkunde, 57(11), 1997, pp. 585-594
95. SOLOMAYER EF; DIEL IJ; WALLWIENER D; BASTERT G
    BREAST-CANCER WITH SKELETAL METASTASES AT INITIAL DIAGNOSIS - ANALYSIS TO PROGNOSIS, COURSE, AND THERAPY
    Geburtshilfe und Frauenheilkunde
    
    E.F. Solomayer et al., "BREAST-CANCER WITH SKELETAL METASTASES AT INITIAL DIAGNOSIS - ANALYSIS TO PROGNOSIS, COURSE, AND THERAPY", Geburtshilfe und Frauenheilkunde, 57(11), 1997, pp. 629-636
96. SOLOMAYER EF; DIEL IJ; WALLWIENER D; BODE S; MEYBERG G; SILLEM M; GOLLAN O; KRAMER MD; KRAINICK U; BASTERT G
    PROGNOSTIC RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER
    British Journal of Cancer
    
    E.F. Solomayer et al., "PROGNOSTIC RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER", British Journal of Cancer, 76(6), 1997, pp. 812-818
97. HOHAUS S; MARTIN S; SCHNEEWEISS A; HUOBER J; FERSIS N; GOLDSCHMIDT H; WALLWIENER D; BASTERT G; HAAS R
    TANDEM HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN 105 PATIENTS WITH HIGH-RISK BREAST-CANCER
    Blood
    
    S. Hohaus et al., "TANDEM HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN 105 PATIENTS WITH HIGH-RISK BREAST-CANCER", Blood, 90(10), 1997, pp. 4560-4560
98. HOESTERMANN CFL; OGBASELASSIE G; WACKER J; BASTERT G
    MATERNAL MORTALITY IN THE MAIN REFERRAL HOSPITAL IN THE GAMBIA, WEST-AFRICA
    TM & IH. Tropical medicine & international health
    
    C.F.L. Hoestermann et al., "MATERNAL MORTALITY IN THE MAIN REFERRAL HOSPITAL IN THE GAMBIA, WEST-AFRICA", TM & IH. Tropical medicine & international health, 1(5), 1996, pp. 710-717
99. WALLWIENER D; AYDENIZ B; RIMBACH S; DIEL IJ; GRISCHKE EM; RABE T; BASTERT G
    CHANGE OF THE SPECTRUM OF UTERUS-PRESERVI NG MYOMA SURGERY
    Gynakologisch-geburtshilfliche Rundschau
    
    D. Wallwiener et al., "CHANGE OF THE SPECTRUM OF UTERUS-PRESERVI NG MYOMA SURGERY", Gynakologisch-geburtshilfliche Rundschau, 36(3), 1996, pp. 118-132
100. SOHN C; WALLWIENER D; KUREK R; HAHN U; SCHIESSER M; BASTERT G
     TREATMENT OF THE TWIN-TWIN TRANSFUSION SYNDROME - INITIAL EXPERIENCE USING LASER-INDUCED INTERSTITIAL THERMOTHERAPY
     Fetal diagnosis and therapy
     
     C. Sohn et al., "TREATMENT OF THE TWIN-TWIN TRANSFUSION SYNDROME - INITIAL EXPERIENCE USING LASER-INDUCED INTERSTITIAL THERMOTHERAPY", Fetal diagnosis and therapy, 11(6), 1996, pp. 390-397